Early Access — free while we kick the tires
EdgarHawk

ACORN BIOVENTURES, L.P.

10% Owner

10% Owner
1 filing analyzed · 1 company · Latest 2025-05-19

Companies

Company Buys Sells Direction
OnKure Therapeutics, Inc. OKUR 2 0 Net buying

Activity

May 2025
medium
Buy
1,400,000 shares
$2,590,000
Significance 6/10

10% owner ACORN BIOVENTURES purchases 1,400,000 shares for $2,590,000 as stock trades 88.6% below 52-week high

ACORN BIOVENTURES, L.P., a 10% owner, executed 2 separate purchases totaling 1,400,000 shares at $1.85 per share on 2025-05-15, investing $2,590,000 total. The transaction occurred while OnKure trades at $2.20, down 88.6% from its 52-week high of $19.21 and declined 61.3% over the past 90 days. The company posted a net loss of $15,925,000 over its most recent full fiscal year, indicating ongoing unprofitability. The purchase by a significant existing shareholder at these depressed levels—only $0.37 above the 52-week low—merits investor attention given the stock's severe drawdown and the filer's substantial ownership stake, though the underlying financial distress limits confidence in the signal.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access